Skip to content

Orthomod

1 viewer · 30d

Total raised

—

1 filing since 2026 · no dollar figures disclosed

No disclosed amounts to chart
LAST ROUND
Equity
ROUNDS
1
INVESTORS
N/A
FOUNDED
N/A
HQ
Dayton, OH
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Orthomod LLC is a Dayton, Ohio medical device company developing structural orthopedic biomaterials and implants for musculoskeletal applications. Its core technology, CAMP (calcium-acrylic modified polymer), is a composite of an acrylic polymer with synthetic beta-tricalcium phosphate and hydroxyapatite that combines natural and synthetic orthobiologics with polymer components. In 2026 the company received FDA 510(k) clearance for the MOD-C cervical intervertebral implant family for degenerative disc disease of the cervical spine (C2-T1), with a clinical launch planned for the second half of 2026. The company targets spine, sports medicine, dental, trauma, and oncology applications.

What sets it apart

CAMP is positioned as a third-generation implant material and an alternative to the titanium and PEEK that dominate spinal implants — microporous and hydrophilic like natural bone, enabling ionic transfer at the implant interface while providing immediate structural support and improved radiographic visibility.

Funding history

1 round
EquityMay 29, 2026 · $25K min
Form D
—— total

Latest SEC filings

via EDGAR · CIK 0002007576
Form D · May 29, 2026NewView on EDGAR

Products

1 tracked

MOD-C Cervical Implant

Spinal implant

An FDA-cleared cervical intervertebral body fusion device family for treating degenerative disc disease of the cervical spine from C2-T1, built from the company's CAMP biomaterial and scheduled for clinical launch in the second half of 2026.

  • FDA 510(k) cleared for degenerative disc disease of the cervical spine (C2-T1)
  • Built from CAMP calcium-acrylic modified polymer composite
  • Microporous, hydrophilic structure similar to natural bone
  • Enables ionic transfer at the implant interface

Links

WebsiteLinkedInSEC EDGAR filings